Collision Tumors Involving Metastatic Carcinoma and Plasma Cell Myeloma: Report of Two Cases

转移性癌与浆细胞骨髓瘤碰撞瘤:两例报告

阅读:1

Abstract

Synchronous coexistence of plasma cell neoplasms (PCNs) and metastatic carcinoma is not a common phenomenon and poses a significant diagnostic challenge requiring meticulous histopathological and immunophenotypic analysis for accurate lineage assignment. We report two cases of collision tumors comprising PCN and metastatic lung carcinoma. Case 1 involved a 68-year-old male with metastatic non-small cell lung adenocarcinoma who developed intracranial lesions; resection revealed metastatic adenocarcinoma intermingled with clonal plasma cells. Case 2 was a 73-year-old woman with a lytic iliac crest lesion whose bone marrow and lesion biopsies showed diffuse infiltration by both carcinoma and atypical plasma cells. Comprehensive immunohistochemical profiling, in situ hybridization (ISH), and molecular studies were performed. In both cases, histology demonstrated two distinct, intermingled cell populations without transitional features. IHC was critical for confirmation: the carcinoma cells expressed epithelial markers (AE1/AE3), whereas the plasma cell components were positive for CD138. ISH in Case 1 and flow cytometry in Case 2 confirmed clonality (kappa light-chain restriction). The final diagnoses were collision tumors of metastatic non-small cell lung adenocarcinoma with synchronous PCN (Case 1) and metastatic small cell carcinoma with synchronous PCN (Case 2). There are sporadic reports of PCN coexistent in the same lesion with solid tumors. These cases reveal the critical role of the pathologist in diagnosing collision tumors. IHC panel, including cytokeratins, CD138, and MUM1, can help in distinguishing these dual populations and avoiding diagnostic pitfalls.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。